207 - Pediatric Respiratory Virus Vaccines

Moderator(s)

• 

  Natasha Halasa, MD (she/her/hers)

  Craig Weaver Professor of Pediatrics
  Division of Pediatric Infectious Diseases
  Vanderbilt University Medical Center
  Nashville, TN, United States
• 

  Paul Spearman, MD (he/him/his)

  Vice Chair for Clinical and Translational Research
  Cincinnati Children's Hospital Medical Center
  Cincinnati, OH, United States

Presentations:

• 10:30 AM - 10:42 AM US ET

  Efficacy and Safety of Retavibart, a Long-acting Monoclonal Antibody, for the Prevention of Respiratory Syncytial Virus-Induced Lower Respiratory Tract Infection: A Phase 2b Trial in Infants Entering Their First Epidemic Season
  

  Co-Author: Yanyan Li, MD – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Presenting Author: Daiyin Tian, MD，PHD – Children's hospital of Chongqing Medical University

  Co-Author: Lingli Pan, MD, PhD – West China Second University Hospital

  Co-Author: Hanmin Liu, MD, PhD – West China Second University Hospital

  Co-Author: Enmei Liu, MD, PhD – Children's Hospital of Chongqing Medical University

  Co-Author: Shiru Zhao, PhD – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Haiyan An, MD – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Xin Zhou, PhD – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Jiyuan Ding, MD, MPH – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Jianli Chu, PhD – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Meizhuo Zhang, PhD – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Ying Wang, BS – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Xiaohu Kuang, MD，PhD – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Xia Zhou, MS – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Zhenxing Jia, MS – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Hao Zhao, MS – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Huaxin Liao, PhD – Zhuhai Trinomab Pharmaceutical Co., Ltd.

  Co-Author: Wanmei wang, MD, PhD – Zhuhai Trinomab Pharmaceutical Co., Ltd.
• 10:42 AM - 10:54 AM US ET

  Reduction of RSV-associated hospitalization rates during the 2024-2025 RSV Season among infants <6 months of age.
  

  Co-Author: Ayzsa Tannis, MPH – Centers for Disease Control and Prevention

  Co-Author: Leah Goldstein, MPH – Centers for Disease Control and Prevention

  Co-Author: Geoffrey A. Weinberg, MD (he/him/his) – University of Rochester Sch Med & Dent

  Co-Author: Mary A. Staat, MD, MPH – Cincinnati Children's Hospital Medical Center

  Co-Author: Daniel C. Payne, PhD, MSPH – Cincinnati Children's Hospital Medical Center

  Co-Author: Natasha B. Halasa, MD (she/her/hers) – Vanderbilt University Medical Center

  Co-Author: Leila C. Sahni, PhD, MPH (she/her/hers) – Baylor College of Medicine and Texas Children's Hospital

  Co-Author: Julie A. Boom, MD – Baylor College of Medicine

  Co-Author: Peter G. Szilagyi, MD MPH – UCLA

  Co-Author: Janet A. Englund, MD (she/her/hers) – Seattle Children’s Hospital/Univ. Washington

  Co-Author: Eileen J. Klein, MD, MPH – Seattle Children's Hospital and University of Washington School of Medicine

  Co-Author: Ariana Toepfer, MPH – Centers for Disease Control and Prevention

  Co-Author: Abigail L. Salthouse, MPH – Centers for Disease Control and Prevention

  Co-Author: Casey M. Kalman, MPH – Centers for Disease Control and Prevention

  Co-Author: Laura S. Stewart, PhD – Vanderbilt University School of Medicine

  Co-Author: John Williams, MD – University of Wisconsin

  Co-Author: Marian G. Michaels, MD, MPH – University of Pittsburgh/ CHP

  Presenting Author: Jennifer E. Schuster, MD (she/her/hers) – Children's Mercy Kansas City

  Co-Author: Rangaraj Selvarangan, PhD – Children’s Mercy Hospital

  Co-Author: Fatimah S. Dawood, MD – CDC

  Co-Author: Heidi L. Moline, MD, MPH – US-CDC
• 10:54 AM - 11:06 AM US ET

  Maternal RSV Vaccine and Nirsevimab Effectiveness against Medically Attended RSV Disease in Infants, United States
  

  Co-Author: Fatimah S. Dawood, MD – CDC

  Co-Author: Ayzsa Tannis, MPH – Centers for Disease Control and Prevention

  Co-Author: Leah Goldstein, MPH – Centers for Disease Control and Prevention

  Presenting Author: Natasha B. Halasa, MD (she/her/hers) – Vanderbilt University Medical Center

  Co-Author: Julie A. Boom, MD – Baylor College of Medicine

  Co-Author: Geoffrey A. Weinberg, MD (he/him/his) – University of Rochester Sch Med & Dent

  Co-Author: Mary A. Staat, MD, MPH – Cincinnati Children's Hospital Medical Center

  Co-Author: Eileen J. Klein, MD, MPH – Seattle Children's Hospital and University of Washington School of Medicine

  Co-Author: John Williams, MD – University of Wisconsin

  Co-Author: Jennifer E. Schuster, MD (she/her/hers) – Children's Mercy Kansas City

  Co-Author: Ariana Toepfer, MPH – Centers for Disease Control and Prevention

  Co-Author: Casey M. Kalman, MPH – Centers for Disease Control and Prevention

  Co-Author: Abigail L. Salthouse, MPH – Centers for Disease Control and Prevention

  Co-Author: Leila C. Sahni, PhD, MPH (she/her/hers) – Baylor College of Medicine and Texas Children's Hospital

  Co-Author: Laura S. Stewart, PhD – Vanderbilt University School of Medicine

  Co-Author: Marian G. Michaels, MD, MPH – University of Pittsburgh/ CHP

  Co-Author: Daniel C. Payne, PhD, MSPH – Cincinnati Children's Hospital Medical Center

  Co-Author: Peter G. Szilagyi, MD MPH – UCLA

  Co-Author: Rangaraj Selvarangan, PhD – Children’s Mercy Hospital

  Co-Author: Janet A. Englund, MD (she/her/hers) – Seattle Children’s Hospital/Univ. Washington

  Co-Author: Heidi L. Moline, MD, MPH – US-CDC
• 11:06 AM - 11:18 AM US ET

  Safety and Immunogenicity of mRNA-1273.815 in COVID-19 Vaccine-Naïve Children 2 Through 4 Years of Age: Results From a Phase 3, Open-Label Trial
  

  Presenting Author: Avika Dixit, MBBS – Moderna, Inc.

  Co-Author: Roozbeh Sharif, MD – REX Clinical Trials, LLC Beaumont

  Co-Author: Rosane Poston, BS – Moderna, Inc.

  Co-Author: Greer Chambers, BS, CPM – Moderna, Inc.

  Co-Author: Anne Yeakey, MD – Moderna, Inc.

  Co-Author: Heather Williams, BS – Moderna, Inc.

  Co-Author: Bethany Girard, Ph.D. – Moderna, Inc.

  Co-Author: Wen Zhou, PhD – Moderna, Inc.

  Co-Author: Wenqin Xu, PhD – Moderna, Inc.

  Co-Author: Spyros Chalkias, MD (he/him/his) – Moderna, Inc.

  Co-Author: Frances Priddy, MD, MPH (she/her/hers) – Moderna, Inc.

  Co-Author: Rituparna Das, M.D. – Moderna, Inc.
• 11:18 AM - 11:30 AM US ET

  Nirsevimab effectiveness in infants against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) and related healthcare utilization
  

  Co-Author: Amber Hsiao, MPH – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: John R. Hansen, MPH – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Julius Timbol, MS – Kaiser Permanente Vaccine Study Center

  Co-Author: Lauren D. Liao, PhD – Kaiser Permanente Vaccine Study Center

  Co-Author: Bruce Fireman, MA – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Ousseny Zerbo, PhD – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Karine Mari, MSc – Sanofi Pasteur S.A.

  Co-Author: Christopher Rizzo, MD – Sanofi

  Co-Author: William V. La Via, MD – Sanofi Pasteur

  Co-Author: Ruvim Izikson, MD, MPH – Sanofi

  Presenting Author: Nicola P. Klein, MD, PhD (she/her/hers) – Division of Research Kaiser Permanente Vaccine Study Center
• 11:30 AM - 11:43 AM US ET

  Nationwide trends in respiratory syncytial virus (RSV) immunizations and RSV immunization efficacy in children aged 2 and under
  

  Presenting Author: Kathryn Lang, MD, PhD (she/her/hers) – VaxCare

  Co-Author: David Alfego, PhD – Labcorp

  Co-Author: Min Kyung Lee, PhD – Labcorp

  Co-Author: Laura Gillim, PhD (she/her/hers) – Labcorp

  Co-Author: Charles M. Walworth, MD (he/him/his) – Monogram Biosciences/LabCorp

  Co-Author: Suzanne Dale, PhD – Labcorp

  Co-Author: Colm Smart, MBA – VaxCare LLC

  Co-Author: Ruth Carrico, PhD, DNP, APRN – Norton Healthcare

  Co-Author: Payman Ghasemi, PhD – VaxCare